CT Coronary Artery Calcification Scoring (CACS) Option for Advantage Windows
510(k) K982004
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK982004 | Date18 Aug 1998 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- JAK
- Device Class
- Class II
- Regulation
- 21 CFR Part 892.1750
- Advisory Committee
- Radiology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
The CT Coronary Artery Calcification Scoring (CACS) Option for Advantage Windows is a software module designed for post-processing and analysis of computed tomography (CT) images. It provides quantitative assessment of coronary artery calcification, a key indicator of atherosclerotic plaque burden and cardiovascular risk. This tool aids radiologists and cardiologists in evaluating coronary artery disease by generating calcium scores from reconstructed CT scans. The software integrates with the Advantage Windows platform to enhance diagnostic workflows for cardiac imaging.
This option is supplied as part of the Advantage Windows software package and operates on compatible CT imaging systems. It is intended for single-use analysis sessions within a clinical or diagnostic radiology setting, though the underlying software may be reusable across multiple scans. The device is not sterile and does not require sterile handling, as it functions as a digital analysis tool rather than a physical implant or consumable. Authorised under FDA 510(k) clearance (K982004), it adheres to regulatory standards for radiology software and is classified under product code JAK.
Other devices from General Electric Co.
Questions
AI-generated answers, 1 Oct 2026
What is the CT Coronary Artery Calcification Scoring (CACS) Option for Advantage Windows used for?
This software module is designed for post-processing and analyzing CT images to provide quantitative assessment of coronary artery calcification. By generating calcium scores from reconstructed CT scans, it helps radiologists and cardiologists evaluate atherosclerotic plaque burden and cardiovascular risk, supporting diagnosis and management of coronary artery disease.
How is the CACS Option supplied and what systems does it integrate with?
The CACS Option is supplied as part of the Advantage Windows software package and is intended for use on compatible CT imaging systems. It integrates directly with the Advantage Windows platform to enhance diagnostic workflows for cardiac imaging, ensuring seamless analysis of coronary artery calcification.
Is the CACS Option for Advantage Windows sterile or single-use?
The CACS Option is not a sterile device, as it functions as a digital analysis tool rather than a physical implant or consumable. It is intended for single-use analysis sessions within a clinical or diagnostic radiology setting, though the underlying Advantage Windows software may be reused across multiple scans.
What regulatory clearance does the CACS Option hold?
The device holds FDA 510(k) clearance under the reference number K982004. It is classified under product code JAK and adheres to regulatory standards for radiology software, having been determined substantially equivalent to a predicate device by the Radiology Advisory Committee.
Can this software be used across different CT imaging systems?
The CACS Option is specifically designed to operate on compatible CT imaging systems that integrate with the Advantage Windows platform. While it enhances workflows for cardiac imaging, compatibility depends on the system’s ability to support the Advantage Windows software environment.